Patents by Inventor Zhi-Dong Jiang

Zhi-Dong Jiang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200147151
    Abstract: The present disclosure provides human fecal microbiota compositions, including fresh, frozen, and lyophilized compositions, for the treatment of disorders associated with dysfunctional microbiota, such as recurrent Clostridium difficile infection. In particular, the fecal microbiota composition comprises a cryoprotectant sugar, such as mannitol.
    Type: Application
    Filed: January 30, 2018
    Publication date: May 14, 2020
    Inventors: Herbert L. DUPONT, Zhi-Dong JIANG
  • Publication number: 20200069664
    Abstract: The present invention provides new methods and kits for treating and preventing bacterial infection.
    Type: Application
    Filed: September 5, 2019
    Publication date: March 5, 2020
    Inventors: Herbert L. Du Pont, Zhi-Dong Jiang, Eric Brown, Charles Darkoh, Pam Golden
  • Publication number: 20130210852
    Abstract: The present invention provides new methods and kits for treating and preventing bacterial infection.
    Type: Application
    Filed: August 16, 2012
    Publication date: August 15, 2013
    Inventors: Herbert L. DuPont, Zhi-Dong Jiang, Eric Brown, Charles Darkoh, Pam Golden
  • Patent number: 6469048
    Abstract: Novel &agr;-pyrones are described. The &agr;-pyrones are useful in a method for controlling &agr;-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an &agr;-pyrone such that control of &agr;-pyrone responsive states in a mammal occurs. &agr;-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel &agr;-pyrones are also described.
    Type: Grant
    Filed: July 30, 1999
    Date of Patent: October 22, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Seth Cohen, Zhi-Dong Jiang
  • Patent number: 6359000
    Abstract: A method of treating cancer with a pharmaceutical composition containing a pine root (Deutero Mycetes) fungal metabolite or an analog or derivative thereof.
    Type: Grant
    Filed: July 12, 1999
    Date of Patent: March 19, 2002
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Wei-Dong Jiang, Zhi-Dong Jiang, Rex T. Gallagher
  • Publication number: 20020004505
    Abstract: Novel &agr;-pyrones are described. The &agr;-pyrones are useful in a method for controlling &agr;-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an &agr;-pyrone such that control of &agr;-pyrone responsive states in a mammal occurs. &agr;-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel &agr;-pyrones are also described.
    Type: Application
    Filed: July 30, 1999
    Publication date: January 10, 2002
    Inventors: SETH COHEN, ZHI-DONG JIANG
  • Patent number: 6060509
    Abstract: A pine root (Deutero mycetes) fungal metabolite and analogs thereof having antifungal activity.
    Type: Grant
    Filed: December 31, 1998
    Date of Patent: May 9, 2000
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventor: Zhi-Dong Jiang
  • Patent number: 5981496
    Abstract: Novel .alpha.-pyrones are described. The .alpha.-pyrones are useful in a method for controlling .alpha.-pyrone responsive states in a mammal. The method includes administering to a mammal a therapeutically effective amount of an .alpha.-pyrone such that control of .alpha.-pyrone responsive states in a mammal occurs. .alpha.-Pyrone responsive states can be associated with undesirable cell proliferation such as bacteria or cancer. Packaged pharmaceuticals and pharmaceutical compositions including the novel .alpha.-pyrones are also described.
    Type: Grant
    Filed: September 19, 1997
    Date of Patent: November 9, 1999
    Assignee: Millennium Pharmaceutical, Inc.
    Inventors: Seth Cohen, Zhi-Dong Jiang
  • Patent number: 5932613
    Abstract: A method of treating cancer with a pharmaceutical composition containing a pine root (Deutero Mycetes) fungal metabolite or an analog or derivative thereof.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: August 3, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: Wei-Dong Jiang, Zhi-Dong Jiang, Rex T. Gallagher
  • Patent number: 5917084
    Abstract: A pine root (Deutero mycetes) fungal metabolite and analogs thereof having antifungal activity.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: June 29, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventor: Zhi-Dong Jiang
  • Patent number: 5888721
    Abstract: The invention features two novel antibiotics, termed 15352A and 15352B, having the structures shown in the figures.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: March 30, 1999
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: David Rothstein, Nagraj Mani, Zhi-Dong Jiang
  • Patent number: 5837726
    Abstract: A natural product of Aspergillus fumigatus and specific derivatives thereof, and a method of treating fungal infection therewith.
    Type: Grant
    Filed: November 1, 1995
    Date of Patent: November 17, 1998
    Assignee: Millennium Pharmaceuticals, Inc.
    Inventors: David Qin Liu, Zhi-Dong Jiang, Rex T. Gallagher, T. Vance Morgan